Quantinno Capital Management LP Increases Position in Intuitive Surgical, Inc. $ISRG

Quantinno Capital Management LP increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 224,448 shares of the medical equipment provider’s stock after purchasing an additional 34,445 shares during the quarter. Quantinno Capital Management LP’s holdings in Intuitive Surgical were worth $103,469,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. State Street Corp increased its position in shares of Intuitive Surgical by 1.0% in the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock valued at $8,892,753,000 after buying an additional 162,264 shares in the last quarter. Capital World Investors lifted its position in shares of Intuitive Surgical by 1.7% during the 4th quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock valued at $4,449,491,000 after buying an additional 127,526 shares in the last quarter. Norges Bank purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $2,856,987,000. Invesco Ltd. grew its stake in Intuitive Surgical by 17.4% in the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after acquiring an additional 611,268 shares during the period. Finally, Wellington Management Group LLP grew its stake in Intuitive Surgical by 9.4% in the 4th quarter. Wellington Management Group LLP now owns 3,445,880 shares of the medical equipment provider’s stock valued at $1,951,609,000 after acquiring an additional 294,651 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on ISRG. Deutsche Bank Aktiengesellschaft cut their price target on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a report on Tuesday, June 2nd. Sanford C. Bernstein dropped their target price on shares of Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. HSBC cut their target price on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Leerink Partners reduced their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Finally, Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Twenty-one research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $519.13.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 119 shares of the firm’s stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total value of $55,156.50. Following the transaction, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares in the company, valued at $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 6,669 shares of company stock valued at $2,822,405. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $356.83 on Tuesday. The business has a fifty day moving average price of $405.22 and a 200 day moving average price of $457.57. The company has a market cap of $126.06 billion, a P/E ratio of 40.87, a P/E/G ratio of 2.44 and a beta of 1.46. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter in the previous year, the company posted $1.81 EPS. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.